Going forward, important support for the Nifty is placed around the level of 10,990, but if Nifty fails to hold this support level, then a correction is expected up to the levels of 10,930-10,900. On the upside, the high of 11,110 might act as immediate resistance for the Nifty, followed by 11,200. Top stocks to watch out: FIEM Industries, Vakrangee, Jagran Prakashan, Havells, FDC, Hind Copper, Capital First, Kokuyo Camlin, Prataap Snacks, Amrutanjan Healthcare, Bharat Forge, and Reliance Industries. 

Indian markets are expected to make an optimistic start on the back of firm global cues. The SGX Nifty suggests that the Nifty may open at 11,129 with a gap-up of 55 points. 

Most of the investors think of averaging down their cost of acquisition when the stock price go down. What does an investor do when the price of stock goes up? Should they purchase more of the stock or book profit?

If your portfolio of investments is tilted heavily either towards equity or fixed income investments, it is advisable to make suitable changesso that it becomes a more balanced portfolio that provides proper diversification.

If you are planning to go out on a holiday next summer, you can benefit from the leave travel allowance (LTA) paid by your employer and make your holiday more enjoyable.

Read on to know what kind of strategy an investor should adopt to take advantage of the rising interest rates, if the RBI raises rates in 2018 and 2019.

It looks like AMFI’s aggressive campaign “Mutual Funds Sahi Hai” over the last one year has really worked wonders and drawn small town investors into the mutual fund fold.

The stocks that are likely to record a significant movement on the bourses on January 29, 2018 are Havells India Limited, FDC Limited, Bharat Forge Limited, Shankara Building Products Limited and Divi’s Laboratories Limited.    

ETFs are gaining popularity even among retail investors. Read on to find the reasons for such rise and factors to consider while selecting right ETF.

Validating the risks for the Indian pharmaceutical companies, credit rating agency ICRA said that the US generic business is expected to remain challenging for the Indian companies in 2018.